Prevalence of antiphospholipid antibodies in patients with sickle cell disease;Prévalence des anticorps antiphospholipides au cours de la drépanocytose homozygote

Annales de Biologie Clinique

Volumn 62, Issue 3, 2004, Pages 291-294

  Diatta, A ^a   Toure Fall A O ^b   Sarr, N G ^a   Diallo, F ^a   Diagne, I ^c   Lopez Sall, P ^b   Wone, I ^b   Vassault, A ^d   Sall, N D ^a   Thiam, D ^b   Toure M ^a  

^a Lab de Biochimie Médicale   (France)

^b UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^c Hopital d'Enfants Albert Royer Dakar   (Senegal)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Antiphospholipid antibodies; Sickle cell disease; Thrombosis

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ARTICLE; BLOOD; FEMALE; HUMAN; MALE; PREVALENCE; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; HUMANS; MALE; PREVALENCE;

EID: 2542522428     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Rauch J, Janoff AS. Phospholipid in hexagonal II phase is immunogenic: evidence for immunorecognilion of non-bilayer lipid phases in vivo. Proc Natl Acad Sci USA 1990 ; 87 : 4112.
2. Lubin BH, Chiu D, Bastacky J, Roelofsen B, Van Deenen LLM. Abnormalilies in membrane phospholipid organization in sickled erythrocytes. J Clin Invest 1981 ; 67 : 1643-9.
3. Chiu D, Lubin B, Shohet SB. Erythrocyte membrane lipid reorganization during the sickling process. Br J Haematol 1979 ; 41 : 223-34.
4. Girol R, De Montalembert M. La drépanocytose est une maladie thrombo-embolique. STV 1992 ; 4 : 113-8.
5. Helley D, Eldor A, Girol R, Ducrocq R. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassemia. Thromb Haemost 1996 ; 6 : 93-9.
6. 2- glycoprotein I is bound to a suitable surface. Thromb Haemost 1995 ; 73 : 29-34.
7. Westerman MP, Kleps R, Unger L, Kucuk O, Lis L. Non-lamellar phases in sickle red cell membranes. Clin Res 1992 ; 40 : 425 A.
8. Kucuk O, Gilman-Sachs A, Beaman K, Lis LJ, Westerman MP. Anti-phospholipid antibodies in sickle cell disease. Am J Hematol 1993 ; 42 : 380-3.
9. Keeling DM, Wilson AJ, Mackie IJ, Machin SJ, Isenberg DA. Some antiphospholipid antibodies bind to beta-2-glycoprotein I in the absence of phospholipid. Br J Haematol 1992 ; 82 : 571-4.
10. Mc Neil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed aganst a complex antigen that includes a lipi-binding inhibitor of coagulation: β-2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990 ; 87 : 4120-4.
11. Harris EN, Gharavi AE, Loizou S, Derne G, Chan JK, Patel BM. Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985 ; 16 : 1-6.
12. Roubey RAS. Antigenic specificities of antiphospholipid autoantibodies implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome. Lupus 1996 ; 5 : 425-30.
13. 2-glycoprotein I. J Lab Clin Med 1993 ; 122 : 426-31.
14. Greaves M. Antiphospholipid antibodies and thrombosis. Lancet 1999 ; 353 : 1348-3.
15. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood 1995 ; 86 : 3685-1.
16. Coull BM, Goodnight SH. Antiphospholipid antibodies, prethrombic stats and stroke. Stroke 1990 ; 21 : 1370-4.
17. Matinuzzo ME, Forastiem RR, Carreras LO. Anti beta-2-glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995 ; 89 : 397-2.
18. Arvieux J, Schweizer B, Roussel B, Colomb MG. Autoimmune hemolytic anaemia due to anti-phospholipid antibodies. Vox Sang 1991 ; 61 : 190-5.